Hypophosphatemia after parenteral iron replacement in patients with inflammatory bowel disease: a case report series
| Autor: | Ljubas Kelečić, Dina, Jelaković, Mislav, Barišić, Ana, Brinar, Marko, Karas, Irena, Vranešić Bender, Darija, Krznarić, Željko |
|---|---|
| Jazyk: | chorvatština |
| Rok vydání: | 2022 |
| Předmět: |
HYPOPHOSPHATEMIA – chemically induced
diagnosis therapy MALTOSE – adverse effects VITAMIN D INFUSIONS INTRAVENOUS INFLAMMATORY BOWEL DISEASES – complications FERRIC COMPOUNDS- administration and dosage adverse effects therapeutic use ANEMIA IRON-DEFICIENCY – drug therapy etiology Deskriptori UPALNE BOLESTI CRIJEVA – komplikacije SIDEROPENIČNA ANEMIJA – etiologija farmakoterapija HIPOFOSFATEMIJA – dijagnoza kemijski izazvana liječenje PRIPRAVCI ŽELJEZA – nuspojave terapijska uporaba MALTOZA – nuspojave INTRAVENSKE INFUZIJE |
| Zdroj: | Liječnički vjesnik Volume 144 Issue 11-12 |
| ISSN: | 0024-3477 1849-2177 |
| DOI: | 10.26800/lv-144-11-12-4 |
| Popis: | SAŽETAK Hipofosfatemija kao nuspojava parenteralne primjene željeza dobro je opisana u dosadašnjoj literaturi, no jasni protokoli ili preporuke o prevenciji, pravodobnom prepoznavanju i liječenju nisu dostupni. Čimbenici rizika koji dovode do pojave hipofosfatemije kod bolesnika s upalnim bolestima crijeva (IBD) nisu jasno utvrđeni te dodatno otežavaju razumijevanje nastanka hipofosfatemije i dugoročnih komplikacija, a time i potrebne korake u adekvatnom pristupu prevenciji i liječenju. Prikazom serije kliničkih slučajeva četiriju IBD bolesnika želimo pokazati heterogenost kliničke prezentacije hipofosfatemije, utjecaja nutritivnih, upalnih i drugih čimbenika te moguće modalitete liječenja. Također, želimo istaknuti koja je skupina IBD bolesnika izložena dodatnom riziku razvoja ove nuspojave s ciljem pravodobnog dijagnosticiranja i početka liječenja. Hypophosphatemia as a side effect of parenteral iron administration has been well described in the recent literature. However clear protocols or recommendations for prevention, timely recognition and treatment are not available. Different data on risk factors in patients with inflammatory bowel disease (IBD) according to the published papers further complicate the understanding of hypophosphatemia and long-term complications, and thus the necessary steps in an adequate approach to prevention and treatment. By presenting a series of clinical cases of four IBD patients, we want to show the heterogeneity of the clinical presentation of hypophosphatemia, the influence of nutritional, inflammatory and other factors and also possible treatment modalities. Furthermore, we want to point out which group of IBD patients is at additional risk of developing hypophoshatemia, with the aim of timely diagnosis and treatment initiation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|